Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison.
- DOI
- 10.1016/j.msard.2026.107953
- Published
- 2026 Nov
- Container
- Multiple sclerosis and related disorders
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.msard.2026.107953,
title = {Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison.},
author = {Gold R and Ansaripour A and Schmierer K and Barnett M and Hartung HP and Yamout B and de Seze J and Selmaj K and Centonze D and Grigoriadis N and Javanbakht M and Miskin H and Schmitt AB and Cutter G},
year = {2026},
journal = {Multiple sclerosis and related disorders},
doi = {10.1016/j.msard.2026.107953},
url = {https://doi.org/10.1016/j.msard.2026.107953}
}RIS
TY - JOUR TI - Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison. AU - Gold R AU - Ansaripour A AU - Schmierer K AU - Barnett M AU - Hartung HP AU - Yamout B AU - de Seze J AU - Selmaj K AU - Centonze D AU - Grigoriadis N AU - Javanbakht M AU - Miskin H AU - Schmitt AB AU - Cutter G PY - 2026 JO - Multiple sclerosis and related disorders DO - 10.1016/j.msard.2026.107953 UR - https://doi.org/10.1016/j.msard.2026.107953 ER -
APA
R, G., A, A., K, S., M, B., HP, H., B, Y., J, D. S., K, S., D, C., N, G., M, J., H, M., AB, S., & G, C. (2026). Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2026.107953
Source records
- pubmed · retrieved 2026-11-10T11:31:46.616Z